News and Analysis

Day One Biopharmaceuticals pockets $60m Series A

Day One Biopharmaceuticals, a developer of new oncology therapies, has raised $60 million in Series A financing.

-

Day One Biopharmaceuticals, a developer of new oncology therapies, has raised $60 million in Series A financing. The backers were Canaan, Access Biotechnology and Atlas Venture.

Source: Press Release